Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Specialty Generics Market Report by Route of Administration (Injectables, Oral, and Others), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, and Others), Distribution channel (Retail Pharmacies, Specialty Pharmacies, Hospital Pharmacies), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A1219
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Specialty Generics Market: Introduction
5 Why are Specialty Generics So Lucrative?
6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors
7 Market Breakup by Route of Administration
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Indication
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Overview
10.1.2 Market Performance
10.1.3 Market Breakup by Country
10.1.3.1 United States
10.1.3.1.1 Market Trends
10.1.3.1.2 Market Forecast
10.1.3.2 Canada
10.1.3.2.1 Market Trends
10.1.3.2.2 Market Forecast
10.1.4 Market Forecast
10.2 Europe
10.2.1 Market Overview
10.2.2 Market Performance
10.2.3 Market Breakup by Country
10.2.3.1 Italy
10.2.3.1.1 Market Trends
10.2.3.1.2 Market Forecast
10.2.3.2 Germany
10.2.3.2.1 Market Trends
10.2.3.2.2 Market Forecast
10.2.3.3 France
10.2.3.3.1 Market Trends
10.2.3.3.2 Market Forecast
10.2.3.4 United Kingdom
10.2.3.4.1 Market Trends
10.2.3.4.2 Market Forecast
10.2.3.5 Spain
10.2.3.5.1 Market Trends
10.2.3.5.2 Market Forecast
10.2.4 Market Forecast
10.3 Asia Pacific
10.3.1 Market Overview
10.3.2 Market Performance
10.3.3 Market Breakup by Country
10.3.3.1 Japan
10.3.3.1.1 Market Trends
10.3.3.1.2 Market Forecast
10.3.3.2 China
10.3.3.2.1 Market Trends
10.3.3.2.2 Market Forecast
10.3.3.3 India
10.3.3.3.1 Market Trends
10.3.3.3.2 Market Forecast
10.3.3.4 South Korea
10.3.3.4.1 Market Trends
10.3.3.4.2 Market Forecast
10.3.4 Market Forecast
10.4 Latin America
10.4.1 Market Overview
10.4.2 Market Performance
10.4.3 Market Breakup by Country
10.4.3.1 Brazil
10.4.3.1.1 Market Trends
10.4.3.1.2 Market Forecast
10.4.3.2 Mexico
10.4.3.2.1 Market Trends
10.4.3.2.2 Market Forecast
10.4.4 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Overview
10.5.2 Market Performance
10.5.3 Market Forecast
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
11.3.1 Teva Pharmaceuticals Industries
11.3.2 Akorn, Inc.
11.3.3 Mylan N.V.
11.3.4 Mallinckrodt
11.3.5 Sandoz International GmbH
11.3.6 Pfizer, Inc.
11.3.7 Sun Pharmaceutical Industries Ltd.
11.3.8 Valeant Pharmaceuticals
11.3.9 Apotex Corp.
11.3.10 Endo International plc.
List of Figures
Figure 1: Global: Specialty Generics Market: Major Drivers and Challenges
Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2023
Figure 4: Global: Specialty Generics Market: Breakup by Indication (in %), 2023
Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2023
Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: Global: Specialty Generics Industry: SWOT Analysis
Figure 9: Global: Specialty Generics Industry: Value Chain Analysis
Figure 10: Global: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 11: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2018 & 2023
Figure 12: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 13: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2018 & 2023
Figure 14: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 15: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2018 & 2023
Figure 16: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 17: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2018 & 2023
Figure 18: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 19: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2018 & 2023
Figure 20: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 21: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2018 & 2023
Figure 22: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 23: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2018 & 2023
Figure 24: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2024-2032
Figure 25: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2018 & 2023
Figure 26: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2024-2032
Figure 27: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2018 & 2023
Figure 28: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2024-2032
Figure 29: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2018 & 2023
Figure 30: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2024-2032
Figure 31: North America: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Italy: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Germany: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: France: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Spain: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Japan: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: China: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: India: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Middle East and Africa: Specialty Generics Market: Breakup by Country (in %), 2023
Figure 67: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2024-2032
List of Tables
Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2024-2032
Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2024-2032
Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2024-2032
Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2024-2032
Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2023 and 2032
Table 11: Global: Specialty Generics Market Structure
Table 12: Global: Specialty Generics Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More